Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside

Rickey E. Carter, Robert F. Woolson

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Pilot studies are often used to transition therapies developed using animal models to a clinical setting. Frequently, the focus of such trials is on estimating the safety in terms of the occurrence of certain adverse events. With relatively small sample sizes, the probability of observing even relatively common events is low; however, inference on the true underlying event rate is still necessary even when no events of interest are observed. The exact upper limit to the event rate is derived and illustrated graphically. In addition, the simple algebraic expression for the confidence bound is seen to be useful in the context of planning studies.

Original languageEnglish (US)
JournalJournal of Translational Medicine
Volume2
DOIs
StatePublished - Oct 28 2004
Externally publishedYes

Fingerprint

Sample Size
Animals
Animal Models
Safety
Planning
Therapeutics

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

@article{e73e780e156e4c70992be3c14a4335f4,
title = "Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside",
abstract = "Pilot studies are often used to transition therapies developed using animal models to a clinical setting. Frequently, the focus of such trials is on estimating the safety in terms of the occurrence of certain adverse events. With relatively small sample sizes, the probability of observing even relatively common events is low; however, inference on the true underlying event rate is still necessary even when no events of interest are observed. The exact upper limit to the event rate is derived and illustrated graphically. In addition, the simple algebraic expression for the confidence bound is seen to be useful in the context of planning studies.",
author = "Carter, {Rickey E.} and Woolson, {Robert F.}",
year = "2004",
month = "10",
day = "28",
doi = "10.1186/1479-5876-2-37",
language = "English (US)",
volume = "2",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Statistical design considerations for pilot studies transitioning therapies from the bench to the bedside

AU - Carter, Rickey E.

AU - Woolson, Robert F.

PY - 2004/10/28

Y1 - 2004/10/28

N2 - Pilot studies are often used to transition therapies developed using animal models to a clinical setting. Frequently, the focus of such trials is on estimating the safety in terms of the occurrence of certain adverse events. With relatively small sample sizes, the probability of observing even relatively common events is low; however, inference on the true underlying event rate is still necessary even when no events of interest are observed. The exact upper limit to the event rate is derived and illustrated graphically. In addition, the simple algebraic expression for the confidence bound is seen to be useful in the context of planning studies.

AB - Pilot studies are often used to transition therapies developed using animal models to a clinical setting. Frequently, the focus of such trials is on estimating the safety in terms of the occurrence of certain adverse events. With relatively small sample sizes, the probability of observing even relatively common events is low; however, inference on the true underlying event rate is still necessary even when no events of interest are observed. The exact upper limit to the event rate is derived and illustrated graphically. In addition, the simple algebraic expression for the confidence bound is seen to be useful in the context of planning studies.

UR - http://www.scopus.com/inward/record.url?scp=18144386952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18144386952&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-2-37

DO - 10.1186/1479-5876-2-37

M3 - Article

VL - 2

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

ER -